Home/Filings/4/0001005477-04-000250
4//SEC Filing

GRAU ULRICH M 4

Accession 0001005477-04-000250

CIK 0000727510other

Filed

Jan 14, 7:00 PM ET

Accepted

Jan 15, 5:03 PM ET

Size

5.4 KB

Accession

0001005477-04-000250

Insider Transaction Report

Form 4
Period: 2003-12-05
GRAU ULRICH M
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2003-12-05+40,00040,381 total
Footnotes (2)
  • [F1]Restricted Stock granted pursuant to the Company's 2001 Incentive Stock Plan and qualified under Rule 16b-3(d). Of the 40,000 shares granted, 12,000 shares vest on 12/5/2006, 12,000 shares vest on 12/5/2007, and 16,000 shares vest on 12/5/2008.
  • [F2]Dr. Grau has acquired 381 shares of the Company's Common Stock under the Enzon 401(k) plan (the "Plan"), which is qualified under Rule 16b-3. The Plan has been amended and Dr. Grau will no longer acquire shares of the Company's Common Stock under the Plan.

Issuer

ENZON PHARMACEUTICALS INC

CIK 0000727510

Entity typeother

Related Parties

1
  • filerCIK 0001169744

Filing Metadata

Form type
4
Filed
Jan 14, 7:00 PM ET
Accepted
Jan 15, 5:03 PM ET
Size
5.4 KB